Professor Juliet Compston, Board member of the International Osteoporosis Foundation (IOF) and the International Bone and Mineral Society (IBMS), has been awarded the prestigious IBMS John G. Haddad, Jr. Award. The Award was presented during the 2nd Joint Conference of the International Bone & Mineral Society and the Australian & New Zealand Bone & Mineral Society, held in Sydney, Australia from March 21 to 25, 2009.
The IBMS John G. Haddad, Jr. Award recognises outstanding contributions to clinical research in bone and mineral metabolism that have led to significant changes in understanding of physiology or disease, or to changes in disease management or prevention.
Juliet Compston is Professor of Bone Medicine and Honorary Consultant Physician at Cambridge University School of Clinical Medicine. She has published more than 300 papers in the field of metabolic bone disease and has a particular interest in the cellular and structural pathophysiology of bone loss associated with osteoporosis and the effects of drugs on these changes. Research interests also include the effects of glucocorticoids in bone, the role of megakaryocytes in bone remodeling and secondary osteoporosis associated with liver transplantation and with cystic fibrosis.
In addition to her clinical and research activities, Professor Compston is Chair of the EU Osteoporosis Consultation Panel, serves as a Trustee of the Medical Board of the National Osteoporosis Society (NOS), and is a member of the MHRA Expert Advisory Group on Women’s Health and of the Osteoporosis Guidelines Development Group for the National Institute of Clinical Excellence (NICE). She is an Associate Editor of the Journal of Bone and Mineral Research and serves on the editorial board of Bone, Osteoporosis International and the Journal of Clinical Endocrinology and Metabolism.
You can read more about Juliet on my website at http://www.cumpston.org.uk/#/juliet-e-compston-prof/4535811008